Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Lymphoma 138Lymphoma, Non-Hodgkin 84Lymphoma, Large B-Cell, Diffuse 83Small Cell Lung Carcinoma 78Hodgkin Disease 61Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Leukemia 57Burkitt Lymphoma 56Lung Neoplasms 49Lymphoma, Follicular 47Lymphoma, Mantle-Cell 44Leukemia, Myeloid, Acute 41Lymphoma, Large-Cell, Immunoblastic 40Multiple Myeloma 33Leukemia, Lymphocytic, Chronic, B-Cell 33Carcinoma, Non-Small-Cell Lung 30Recurrence 26Neuroblastoma 25Lymphoma, B-Cell, Marginal Zone 25Central Nervous System Neoplasms 24Ovarian Neoplasms 18Sarcoma 17Brain Neoplasms 17Dendritic Cell Sarcoma, Interdigitating 16Congenital Abnormalities 16Lymphoma, Large-Cell, Anaplastic 15Breast Neoplasms 15Testicular Neoplasms 14Neoplasms, Plasma Cell 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

pembrolizumab 6Mitotane 5Cisplatin 5cabozantinib 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Doxorubicin 3sodium thiosulfate 2relacorilant 2cixutumumab 2cemiplimab 2camrelizumab 2apatinib 2Radiotherapy 2Nivolumab 2Ipilimumab 2Etoposide 2Cytoreduction Surgical Procedures 2milademetan 1lenvatinib 1gossypol acetic acid 1dostarlimab 1cabazitaxel 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Tamoxifen 1Suramin 1Sunitinib 1Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Adrenocortical Carcinoma × Etoposide × Clear all
NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting
80 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00001339 2008-03-04

A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡